UPF1 Contributes to the Maintenance of Endometrial Cancer Stem Cell Phenotype by Stabilizing LINC00963

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2022 Mar 23

PMID 35318304

Authors

Hao Chen

Jian Ma

Fanfei Kong

Ning Song

Cuicui Wang

Xiaoxin Ma

Affiliations

Soon will be listed here.

Abstract

Endometrial cancer stem cells (ECSCs) play a vital role in endometrial cancer (EC) metastasis, relapse, and chemoresistance. However, the molecular mechanisms that sustain ECSCs remain elusive. Here, we showed that the expression of UPF1 was upregulated in EC tissues and ECSCs and correlated with poor clinicopathological characteristics. UPF1 silencing suppressed ECSC hallmarks, such as sphere formation ability, carboplatin resistance, migration and invasion, and cell cycle progression. UPF1 regulated the behavior and fate of ECSCs by stabilizing LINC00963. LINC00963 further shares the same miRNA response element with the core transcription factor SOX2 and relieved the suppression of SOX2 by miR-508-5p in self-renewing ECSCs. Notably, inhibition of UPF1 and LINC00963 in combination severely impaired the in vivo tumorigenic potential of ECSCs. We demonstrate that the UPF1/LINC00963/miR-508-5p/SOX2 axis has potential value in modulating ECSC maintenance, chemoresistance, and tumorigenesis in EC, which highlights a novel promising target for EC treatment.

Citing Articles

Engineered exosomes restore miR-508-5p expression in uterine corpus endometrial carcinoma and reduce tumor progression and metastasis by targeting DLL3.

Li Y, Liu H, Feng J, Tian W, Du J, Zhang L Front Oncol. 2025; 15:1532564.

PMID: 40066092 PMC: 11891050. DOI: 10.3389/fonc.2025.1532564.

LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1.

Yuan H, Zhou L, Hu W, Yang M Sci Rep. 2025; 15(1):2997.

PMID: 39848992 PMC: 11757752. DOI: 10.1038/s41598-025-86287-2.

WTAP/IGF2BP3 mediated m6A modification of the EGR1/PTEN axis regulates the malignant phenotypes of endometrial cancer stem cells.

Wang B, Wang Y, Wang W, Wang Z, Zhang Y, Pan X J Exp Clin Cancer Res. 2024; 43(1):204.

PMID: 39044249 PMC: 11264439. DOI: 10.1186/s13046-024-03120-w.

LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p.

Wu C, Yang J, Lin X, Wu J, Yang C, Chen S J Cancer. 2024; 15(6):1718-1730.

PMID: 38370382 PMC: 10869986. DOI: 10.7150/jca.91184.

Characterization of a rhabdomyosarcoma reveals a critical role for SMG7 in cancer cell viability and tumor growth.

Steiner A, Zheng Y, Tang Y Sci Rep. 2023; 13(1):10152.

PMID: 37349371 PMC: 10287741. DOI: 10.1038/s41598-023-36568-5.

References

Xu Q, Ge Q, Zhou Y, Yang B, Yang Q, Jiang S . MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway. EBioMedicine. 2020; 51:102609. PMC: 7000338. DOI: 10.1016/j.ebiom.2019.102609. View

Lu H, Ju D, Yang G, Zhu L, Yang X, Li J . Targeting cancer stem cell signature gene SMOC-2 Overcomes chemoresistance and inhibits cell proliferation of endometrial carcinoma. EBioMedicine. 2018; 40:276-289. PMC: 6412073. DOI: 10.1016/j.ebiom.2018.12.044. View

Wortman B, Bosse T, Nout R, Lutgens L, van der Steen-Banasik E, Westerveld H . Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial. Gynecol Oncol. 2018; 151(1):69-75. DOI: 10.1016/j.ygyno.2018.07.020. View

Urick M, Bell D . Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 2019; 19(9):510-521. PMC: 7446243. DOI: 10.1038/s41568-019-0177-x. View

Emons G, Kim J, Weide K, de Gregorio N, Wimberger P, Trillsch F . Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6). Int J Gynecol Cancer. 2021; 31(7):1075-1079. DOI: 10.1136/ijgc-2021-002703. View

Shi L, Gu Q, Zhang F, Li D, Ye W, Zhong Y . Predictive factors of surgical site infection after hysterectomy for endometrial carcinoma: a retrospective analysis. BMC Surg. 2021; 21(1):292. PMC: 8201671. DOI: 10.1186/s12893-021-01264-6. View

Rasmussen T . Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs. Semin Cancer Biol. 2018; 57:36-44. DOI: 10.1016/j.semcancer.2018.09.009. View

Dittmer J . Breast cancer stem cells: Features, key drivers and treatment options. Semin Cancer Biol. 2018; 53:59-74. DOI: 10.1016/j.semcancer.2018.07.007. View

Carvalho M, Laranjo M, Abrantes A, Casalta-Lopes J, Sarmento-Santos D, Costa T . Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism. Pathol Oncol Res. 2018; 25(3):1163-1174. DOI: 10.1007/s12253-018-0535-0. View

10.

Hubbard S, Friel A, Kumar B, Zhang L, Rueda B, Gargett C . Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res. 2009; 69(21):8241-8. DOI: 10.1158/0008-5472.CAN-08-4808. View

11.

Zhu C, Zhang L, Zhao S, Dai W, Xu Y, Zhang Y . UPF1 promotes chemoresistance to oxaliplatin through regulation of TOP2A activity and maintenance of stemness in colorectal cancer. Cell Death Dis. 2021; 12(6):519. PMC: 8140095. DOI: 10.1038/s41419-021-03798-2. View

12.

Wang X, Yu X, Wei W, Liu Y . Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2. Environ Toxicol. 2020; 35(9):998-1006. DOI: 10.1002/tox.22936. View

13.

Lou C, Shao A, Shum E, Espinoza J, Huang L, Karam R . Posttranscriptional control of the stem cell and neurogenic programs by the nonsense-mediated RNA decay pathway. Cell Rep. 2014; 6(4):748-64. PMC: 3962089. DOI: 10.1016/j.celrep.2014.01.028. View

14.

Han S, Cao D, Sha J, Zhu X, Chen D . LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2. Mol Oncol. 2020; 14(5):1074-1088. PMC: 7191191. DOI: 10.1002/1878-0261.12631. View

15.

Shao L, He Q, Liu Y, Liu X, Zheng J, Ma J . UPF1 regulates the malignant biological behaviors of glioblastoma cells via enhancing the stability of Linc-00313. Cell Death Dis. 2019; 10(9):629. PMC: 6700115. DOI: 10.1038/s41419-019-1845-1. View

16.

Dong W, Dai Z, Liu F, Guo X, Ge C, Ding J . The RNA-binding protein RBM3 promotes cell proliferation in hepatocellular carcinoma by regulating circular RNA SCD-circRNA 2 production. EBioMedicine. 2019; 45:155-167. PMC: 6642271. DOI: 10.1016/j.ebiom.2019.06.030. View

17.

Gao L, Guo Q, Li X, Yang X, Ni H, Wang T . MiR-873/PD-L1 axis regulates the stemness of breast cancer cells. EBioMedicine. 2019; 41:395-407. PMC: 6444076. DOI: 10.1016/j.ebiom.2019.02.034. View

18.

Liao M, Liao W, Xu N, Li B, Liu F, Zhang S . LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2. EBioMedicine. 2019; 41:200-213. PMC: 6444057. DOI: 10.1016/j.ebiom.2019.01.035. View

19.

Bi X, Guo X, Mo B, Wang M, Luo X, Chen Y . LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis. EBioMedicine. 2019; 50:408-420. PMC: 6921299. DOI: 10.1016/j.ebiom.2019.11.024. View

20.

Cheng D, Deng J, Zhang B, He X, Meng Z, Li G . LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 2018; 36:159-170. PMC: 6197532. DOI: 10.1016/j.ebiom.2018.08.055. View